Table 1.

Baseline demographic and clinical characteristics of SIVD-WMH patients and controls

	SIVD-WMH patients (n = 17)	Control subjects (n = 17)
Age (yrs )	74.6 ± 8	74.4 ± 8
Sex ratio (m/f)	9/8	9/8
WMH score (Fazekas)	3 ± 0	1 ± 1
MMSE score	22 ± 5	28.5 ± 1
RAVLT immediate recall score	10 ± 12	32 ± 14
RAVLT delayed recall score	1 ± 2	6 ± 4
Trailmaking A (sec)	168 ± 116	45 ± 13
Trailmaking B (sec)	653 ± 320	105 ± 42
Verbal fluency (number / 60 sec)	20 ± 5.7	10 ± 4.8

Values are expressed as mean ± SD unless otherwise indicated.